News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: InternetForumUser post# 246616

Thursday, 12/24/2015 1:32:37 AM

Thursday, December 24, 2015 1:32:37 AM

Post# of 347009
its all smoke and mirrors. Hmmm, before I depart one question I'll hopefully get answered.

Margaret Hamburg ex-FDA Commish who left in March 2015 and now since I know was related to a hedge fund manager at Renaissance, had to sell stocks/funds back in 2009 before she got into the FDA but I wonder if there is a time period before she or her husband could buy into PPHM (if she knew of any possible, positive FDA decisions pending that may be coming....)

She certainly would not depart for no reason at all


-------------------------------------------------------
Dr. Hamburg, 59, told colleagues in an email that she would depart at the end of March.

http://www.nytimes.com/2015/02/06/health/margaret-hamburg-fda-commissioner-stepping-down.html?_r=0
-------------------------------------------------------


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y